At PMV, we believe that by specifically targeting each mutant p53 we can fundamentally disrupt the course of cancer. Our research and development efforts are dedicated to selectively targeting mutant p53, providing unique therapies for any patient whose tumor harbors these gene mutations.

PMV Pharma was founded in 2013 by David Mack, Ph.D., Arnold Levine, Ph.D. and Thomas Shenk, Ph.D. Over the past ten years, we have built a precision oncology platform that leverages more than four decades of research experience and unique insights into the p53 protein. We have assembled a management team of biopharmaceutical experts with extensive experience in oncology drug discovery and development.

Management

David Mack photo

David H. Mack, Ph.D.

Co-Founder, President & CEO

Deepika Jalota photo

Deepika Jalota, Pharm.D.

Chief Development Officer

Michael Carulli photo

Michael Carulli

Chief Financial Officer

Marc Fellous

Marc Fellous, M.D.

Senior Vice President, Head of Clinical Development and Medical Affairs

Tim Smith photo

Tim Smith

Senior Vice President, Head of Corporate Development & Investor Relations

Robert Ticktin photo

Robert Ticktin

General Counsel & Head of Operations

Binh Vu photo

Binh Vu, Ph.D.

Senior Vice President, Drug Discovery and CMC

Laura De Leon photo

Laura De Leon

Vice President, Head of Clinical Operations

Arshad Haque

Arshad Haque, M.D.

Vice President, Drug Safety and Pharmacovigilance

Masha Poyurovsky

Masha Poyurovsky, Ph.D.

Vice President, Biology

J.D. Kern

J.D. Kern

Vice President, Controller

Crystal Zuckerman

Crystal Zuckerman

Vice President, Human Resources

Shibu Sleeba

Shibu Sleeba

Vice President, Information Technology

Board of Directors

Richard A. Heyman photo

Richard A. Heyman, Ph.D.

Chair, Board of Directors and Member, Scientific Advisory Board

Arnold Levine photo

Arnold Levine, Ph.D.

Co-Founder & Member, Scientific Advisory Board

David Mack photo

David H. Mack, Ph.D.

Co-Founder, President & CEO

Laurie Stelzer photo

Laurie Stelzer

Chief Financial Officer, ReNAgade Therapeutics

Scientific Advisory Board

Scott Lowe photo

Scott Lowe, Ph.D.

Chair, Scientific Advisory Board

Karen Vousden photo

Karen Vousden, Ph.D.

Member, Scientific Advisory Board

Frank McCormick photo

Frank McCormick, Ph.D., F.R.S.

Member, Scientific Advisory Board

Arnold Levine photo

Arnold Levine, Ph.D.

Co-Founder & Member, Scientific Advisory Board

Thomas Shenk photo

Thomas Shenk, Ph.D.

Co-Founder & Member, Scientific Advisory Board

Charles Sawyers photo

Charles Sawyers, M.D.

Member, Scientific Advisory Board

Michael Jung photo

Michael E. Jung, Ph.D.

Member, Scientific Advisory Board

Richard A. Heyman photo

Richard A. Heyman, Ph.D.

Member, Scientific Advisory Board

Guillermina (Gigi) Lozano photo

Guillermina (Gigi) Lozano, Ph.D.

Member, Scientific Advisory Board